MORE►
Jaan Biotherapeutics
Left: Daniel Hargrove, co-founder and CEO of InterAct Therapeutics; Right: Isaac Chan, MD, PhD, Co-founder and CSO of InterAct Therapeutics [Photos: LinkedIn]
UTSW Spinout InterAct Therapeutics Selected by Cell & Gene Therapy Incubator Program
by Sandra Engelland | Dec 11, 2025
InterAct, which launched inside BioLabs at Pegasus Park, is a preclinical stage biotech company developing AAV8-based gene therapies for metastatic cancer, with an initial focus on breast cancer-derived liver metastases.
Related Articles
Department of Energy Backs Solidion’s Push to Develop U.S.-Made Battery Graphite
Texas A&M, Last Energy to Launch Microreactor Pilot at RELLIS as Texas Power Demand Climbs
UT Dallas Researchers Turn Everyday Objects into Augmented Reality Keyboards
HF Controls’ $450K Gift Backs Nuclear and AI Research at UTA
CPRIT Awards Grants to 15 Dallas-Fort Worth Researchers in Latest Funding Round
MORE►
Trending
North Texas is a big place, with plenty to do, see, hear, and watch. We scour the internet every week to find events and activities for you. As always, things may change at any time, so be sure to check the official website or registration page for the latest details....
Dallas-Fort Worth is charting its own path in artificial intelligence. From applied AI to research and engineering advances, our region leads in advancing real-world solutions. Behind every breakthrough and solution are the people making it happen....
Amidst its 25th anniversary, Bioworld Merchandising, a leading global pop culture merchandising brand, is launching Bioworld Ventures, a new corporate venture fund designed to support and accelerate high-potential consumer brands around the world....
New York-based Sky Harbour Group (NYSE: SKYH, SKYH WS), an airport infrastructure company building “the first nationwide network” of Home Base Operator (HBO) campuses for business aircraft, has received approval from the Dallas City Council to authorize the execution of ground lease agreements for the development of Sky Harbour HBO campuses at Dallas Love Field and Dallas Executive Airport....
Interact Therapeutics, a Dallas-based cancer cell and gene therapy company with links to UT Southwestern and Pegasus Park’s BioLabs, is one of six startups selected for the second cohort of Charles River Laboratories International’s Cell & Gene Therapy Incubator Program (CIP)....
Trending
North Texas is a big place, with plenty to do, see, hear, and watch. We scour the internet every week to find events and activities for you. As always, things may change at any time, so be sure to check the official website or registration page for the latest details....
Dallas-Fort Worth is charting its own path in artificial intelligence. From applied AI to research and engineering advances, our region leads in advancing real-world solutions. Behind every breakthrough and solution are the people making it happen....
Amidst its 25th anniversary, Bioworld Merchandising, a leading global pop culture merchandising brand, is launching Bioworld Ventures, a new corporate venture fund designed to support and accelerate high-potential consumer brands around the world....
New York-based Sky Harbour Group (NYSE: SKYH, SKYH WS), an airport infrastructure company building “the first nationwide network” of Home Base Operator (HBO) campuses for business aircraft, has received approval from the Dallas City Council to authorize the execution of ground lease agreements for the development of Sky Harbour HBO campuses at Dallas Love Field and Dallas Executive Airport....
Interact Therapeutics, a Dallas-based cancer cell and gene therapy company with links to UT Southwestern and Pegasus Park’s BioLabs, is one of six startups selected for the second cohort of Charles River Laboratories International’s Cell & Gene Therapy Incubator Program (CIP)....
